Eli Lilly (LLY) Other Non-Current Liabilities (2009 - 2026)
Eli Lilly's Other Non-Current Liabilities came in at $7.34 billion for Q2 2026, up 29.2% from $5.68 billion a year earlier and up 38.9% from the prior quarter.
Eli Lilly (LLY) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Eli Lilly's Other Non-Current Liabilities was $5.88 billion, up 44.7% from FY2024.
- Other Non-Current Liabilities has increased in each of the last three years, with a five-year compound annual growth rate of 8.9% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $4.06 billion in FY2024 (+5.5%), $3.85 billion in FY2023 (+3.8%), $3.71 billion in FY2022 (-5.4%) and $3.92 billion in FY2021 (+2.1%).
- The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities in data going back to Q2 2009.
- Year-over-year, Other Non-Current Liabilities increased in seven of the last eight quarters, with growth averaging 30.3%.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2025 (growth of 62.6%), and the weakest in Q2 2023 (a decline of 6.4%).
- Business Quant data shows LLY's Other Non-Current Liabilities at $5.29 billion (Q1 2026), $5.88 billion (Q4 2025) and $6.29 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 135.25 Bn | 107.26 Bn | 2.84 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.81 Bn |
| Mar 31, 2026 | 9.37 Bn |
| Dec 31, 2025 | 9.85 Bn |
| Sep 30, 2025 | 10.07 Bn |
| Jun 30, 2025 | 8.03 Bn |
| Mar 31, 2025 | 7.66 Bn |
| Dec 31, 2024 | 7.54 Bn |
| Sep 30, 2024 | 6.12 Bn |
| Jun 30, 2024 | 5.97 Bn |
| Mar 31, 2024 | 6.46 Bn |
| Dec 31, 2023 | 6.09 Bn |
| Sep 30, 2023 | 5.37 Bn |
| Jun 30, 2023 | 5.28 Bn |
| Mar 31, 2023 | 5.66 Bn |
| Dec 31, 2022 | 5.53 Bn |
| Sep 30, 2022 | 5.49 Bn |
| Jun 30, 2022 | 5.34 Bn |
| Mar 31, 2022 | 5.69 Bn |
| Dec 31, 2021 | 5.56 Bn |
| Sep 30, 2021 | 5.52 Bn |
Eli Lilly Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LLY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();